Introduction
============

Cardiovascular Magnetic Resonance CMR has provided the opportunity to quantify right ventricular (RV) parameters with excellent reproducibility and accuracy. The role of the RV is gaining ground in thalassemia major (TM) patients and this population could experience different "normal" RV values due to chronic anemia and eventually pre-existing iron burdens. In literature, there are no data on the ranges for "normal" RV volumes and ejection fraction (EF) in TM patients. The aim of this study was to establish the ranges for normal RV volumes, mass and ejection fraction normalized to the influence of body surface area (BSA), age and sex from CMR in a large cohort of well-treated TM patients without myocardial iron overload.

Materials
=========

Among the 923 TM patients enrolled in the Myocardial Iron Overload (MIOT) network who underwent CMR for the assessment of cardiac iron overload, function and fibrosis, we selected 142 patients with no known risk factors or history of cardiac disease, normal electrocardiogram, no myocardial iron overload (all the cardiac segments with a normal T2\* value) and no myocardial fibrosis. All patients had been regularly transfused and chelated since early childhood. Moreover, we studied 71 healthy subjects matched for age and sex. RV function parameters were quantitatively evaluated in a standard way by SSFP cine images using MASS® software. RV end-diastolic volume (EDV), end-systolic volume (ESV) and stroke volume (SV) were normalized by body surface area (EDVI, ESVI, SVI).

Results
=======

Table [1](#T1){ref-type="table"} shows the comparison of the CMR parameters with differentiation for sex and age in TM patients and healthy subjects and the cut-off of normality defined as mean - 2 standard deviation (SD). TM patients showed significantly lower BSA than the controls (P\<0.0001). TM males (except age group 14-20 yrs) showed significantly higher RV EF compared to controls. In TM patients all LV volumes indexes were significantly larger in males than in females (P\<0.0001 in all age groups). The EF was not different between the sexes. In males as well as in females the RV volumes were no significant different among the age groups, while in males the EF was significant different (P=0.004).

                   \< 14          14-20       20-30   30-40          \>=40                                                                                                          
  ---------------- -------------- ----------- ------- -------------- --------- ------- -------------- ---------- -------- -------------- --------- ------- -------------- --------- ----------
                   **TM**         **H**       **P**   **TM**         **H**     **P**   **TM**         **H**      **P**    **TM**         **H**     **P**   **TM**         **H**     **P**
                                                                                                                                                                                    
  **Males**        *N=7*          *N=7*               *N=6*          *N=6*             *N=25*         *N=15*              *N=23*         *N=11*            *N=6*          *N=5*     
                                                                                                                                                                                    
  EDVI (ml/m^2^)   88 ±16 (56)    80 ± 12     0.309   89 ± 16 (57)   89 ± 17   0.946   96 ± 21 (54)   103 ± 17   0.245    91 ± 16 (59)   82 ± 13   0.139   90 ± 13 (64)   81 ± 9    0.228
  ESVI (ml/m^2^)   26 ± 3 (20)    31 ± 8      0.273   36 ± 7 (22)    35 ± 9    0.931   34 ± 8 (18)    44 ± 12    0.0004   33 ± 8 (17)    33 ± 8    0.952   28 ± 6 (16)    35 ± 3    0.045
  SVI (ml/m^2^)    61 ± 16 (29)   49 ± 6      0.108   53 ± 11 (31)   54 ± 10   0.836   61 ± 18 (25)   60 ± 9     0.882    58 ± 11 (36)   46 ± 17   0.010   62 ± 8 (46)    46 ± 8    0.007
  EF (%)           68 ± 6 (56)    62 ± 5      0.048   59 ± 5 (49)    61 ± 5    0.579   64 ± 4 (56)    58 ± 6     0.001    64 ± 5 (54)    61 ± 7    0.189   69 ± 3 (63)    57 ± 5    \<0.0001
                                                                                                                                                                                    
  **Females**      *N=2*          *N=2*       *N=2*                  *N=8*     *N=6*                  *N=24*     *N=6*                   *N=33*    *N=8*                  *N=8*     *N=5*
                                                                                                                                                                                    
  EDVI (ml/m^2^)   53 ± 16 (21)   61 ± 1      0.587   77 ± 8 (61)    79 ± 9    0.866   78 ± 14 (50)   78 ± 12    0.990    73 ± 13 (47)   77 ± 9    0.427   74 ± 11 (52)   70 ± 16   0.648
  ESVI (ml/m^2^)   18 ± 1 (17)    20 ±**4**   0.656   29 ± 5         30 ± 5    0.777   28 ± 8 (12)    31 ± 9     0.378    24 ± 7         26 ± 6    0.317   26 ± 5 (16)    25 ± 12   0.922
  SVI (ml/m^2^)    35 ± 5 (25)    41 ± 3      0.635   47 ± 4 (39)    49 ± 7    0.673   51 ± 9 (33)    47 ± 7     0.384    49 ± 8 (30)    51 ± 10   0.738   47 ± 6 (35)    45 ± 5    0.517
  EF (%)           64 ± 9 (46)    68 ± 6      0.687   62 ± 3 (56)    62 ± 6    0.997   65 ± 6 (53)    61 ± 7     0.171    68 ± 5 (58)    66 ± 8    0.329   67 ± 7 (55)    66 ± 8    0.862

Conclusion
==========

In a large cohort of well-treated TM patients males showed significantly higher RV EF compared to controls. Appropriate "normal" reference ranges normalized to BSA, sex and age should be used to avoid misdiagnosis of cardiomiopathy in the clinical arena in TM patients.
